Telma NB Tablet

Telma-NB Tablet is a combination of two anti hypertensive medications. It contains two active ingredients including Nebivolol (5mg) and Telmisartan (40mg). It is prescribed to treat and manage hypertension (high blood pressure) by controlling the blood pressure.

Its compositions like Nebivolol works to reduce heart rate & relax blood vessels and Telmisartan, is an angiotensin II receptor blocker that relaxes blood vessels & lower blood pressure. This medicine also reduces the chances of any future heart attack and stroke. Take it exactly as prescribed by the doctor.​

• Hypertension (high blood pressure)

Some of the medications caused side effects just like that Telma NB tablet may also lead to certain side effects in some patients. Discuss with the doctor if any of these symptoms persist or worsen:

• Headache
• Dizziness
• Weakness
• Cold extremities
• Numbness of extremity
• Increased potassium level in blood
• Slow heart rate
• Decreased blood pressure
• Tiredness
• Paresthesia (tingling or pricking sensation)
• Edema (swelling)

• Take Telma NB tablet in exact dose as prescribed by the doctor. The typical dose of this capsule varies with age and overall health factor of the patient. It can be taken with or without food but at a fixed time each day to get better results.
• It should be swallowed as a whole with water without crushing, chewing, or opening the capsule. Don't miss a dose or overdose the medicine.​
  

• Telma-NB Tablet is a combination of two anti hypertensive medications. It contains two active ingredients including Nebivolol (5mg) and Telmisartan (40mg). Telmisartan, is an angiotensin II receptor blocker that relaxes blood vessels and lowering blood pressure.
• While Nebivolol is a beta-1 adrenergic blocker which works by reducing heart rate and promoting vasodilation via nitric oxide to reduce blood pressure. Together this combination treat hypertension and chronic heart failure.​​
  

• Seleme, V. B., Marques, G. L., Mendes, A. E. M., Rotta, I., Pereira, M., Júnior, E. L., & da Cunha, C. L. P. (2021). Nebivolol for the Treatment of Essential Systemic Arterial Hypertension: A Systematic Review and Meta-Analysis: VB Seleme et al. American Journal of Cardiovascular Drugs, 21(2), 165-180. https://pubmed.ncbi.nlm.nih.gov/32710438/
• Battershill, A. J., & Scott, L. J. (2006). Telmisartan: a review of its use in the management of hypertension. Drugs, 66(1), 51-83. https://pubmed.ncbi.nlm.nih.gov/16398568/
• Cicero, A. F., Kuwabara, M., & Borghi, C. (2018). A critical review of nebivolol and its fixed-dose combinations in the treatment of hypertension. Drugs, 78(17), 1783-1790. https://pubmed.ncbi.nlm.nih.gov/30426333/
• Lim, S., Kook, H., Yu, C. W., Kim, J. H., Cha, J. J., Joo, H. J., ... & Lim, D. S. (2026). Differential effects of antihypertensive drugs on central blood pressure: a randomized comparison between nebivolol and telmisartan. American Journal of Hypertension, 39(2), 303-311. https://pubmed.ncbi.nlm.nih.gov/40490940/
• Pratik, A. H., & Kafeel, R. Comparative effectiveness of Telmisartan, Olmesartan, and Nebivolol in essential hypertension. https://jcdronline.org/index.php/JCDR/article/view/8012
• Kumbla, D. K. (2024). Drug Corner Hypertension Therapeutics Reimagined: Nebivolol and Telmisartan—A Contemporary Review. J Indian Med Assoc, 122(3), 69-74.
• Fountoulaki, K., Dimopoulos, V., Giannakoulis, J., Zintzaras, E., & Triposkiadis, F. (2005). Left ventricular mass and mechanics in mild-to-moderate hypertension: effect of nebivolol versus telmisartan. American journal of hypertension, 18(2), 171-177. https://pubmed.ncbi.nlm.nih.gov/15752943/